Approval from World Health Organization (WHO) Prequalification (WHO PQ) for Amodiaquine Hydrochloride USP
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Anuh Pharma Ltd has received WHO Prequalification approval for its Amodiaquine Hydrochloride USP, an anti-malarial Active Pharmaceutical Ingredient. Amodiaquine Hydrochloride is an essential WHO-listed medicine used in combination therapies for treating uncomplicated Plasmodium falciparum malaria. The prequalification qualifies the company as a supplier for WHO-procured and donor-funded international programmes. This strengthens Anuh Pharma's positioning as a preferred API supplier for global anti-malarial initiatives.
WHO prequalification opens access to large-scale international procurement channels, which could drive meaningful export revenue growth for the company going forward.